A

ABio-X

North America, Massachusetts, United States, Waltham

Description

ABIO-X incubates organizations at the intersection of ground-breaking technologies.

Investor Profile

ABio-X has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Oncology
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ABio-X frequently co-invest with?

CBC Group
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Cenova
Asia, Shanghai, China, Shanghai
Co-Investments: 1
LIGHTHOUSE
Asia, Beijing, China, Beijing
Co-Investments: 1
Trinity Innovation Fund
Asia, Beijing, China, Beijing
Co-Investments: 1
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
Delta Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Partners Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Quan Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
GGV Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by ABio-X?

Adcentrx Therapeutics

San Diego, California, United States

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

BiotechnologyPharmaceutical
Series AApr 24, 2023
Amount Raised: $51,000,000
ENSEM Therapeutics

Medford, Massachusetts, United States

ENSEM Therapeutics is a biotechnology company focusing on high value and difficult-to-drug oncology targets

BiotechnologyOncologyTherapeutics
Series AApr 6, 2022
Amount Raised: $67,000,000